CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2023 | $2 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2023 | $2 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.9% | 2,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 2,000 | -4.8% | 0.00% | – |
Q4 2021 | $5,000 | -58.3% | 2,100 | -32.3% | 0.00% | -100.0% |
Q3 2021 | $12,000 | -47.8% | 3,100 | -80.7% | 0.00% | 0.0% |
Q2 2021 | $23,000 | +1050.0% | 16,100 | +1138.5% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 1,300 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | – | 1,300 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 1,300 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -98.8% | 1,300 | -91.6% | 0.00% | -100.0% |
Q2 2018 | $84,000 | +833.3% | 15,400 | +1611.1% | 0.01% | +600.0% |
Q1 2018 | $9,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |